Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleLetters to the Editor

Tenofovir Disoproxil Fumarate Is Not an Inhibitor of Human Organic Cation Transporter 1

Hong Shen, Wenying Li, W. Griffith Humphreys and Yurong Lai
Journal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 341-342; DOI: https://doi.org/10.1124/jpet.116.238337
Hong Shen
Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Princeton, New Jersey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenying Li
Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Princeton, New Jersey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. Griffith Humphreys
Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Princeton, New Jersey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yurong Lai
Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Princeton, New Jersey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 360 no. 2 341-342
DOI 
https://doi.org/10.1124/jpet.116.238337
PubMed 
28104831

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online January 19, 2017.

Copyright & Usage 
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

Statistics from Altmetric.com

Article usage

Article usage: January 2017 to February 2021

AbstractFullPdf
Jan 201705538
Feb 201701512
Mar 201701410
Apr 2017055
May 201701010
Jun 2017052
Jul 201701214
Aug 20170135
Sep 2017064
Oct 201701510
Nov 2017052
Dec 2017024
Jan 2018087
Feb 201802112
Mar 20180199
Apr 201802518
May 201802817
Jun 201803516
Jul 20180711
Aug 201801711
Sep 201801711
Oct 201801418
Nov 201802716
Dec 20180918
Jan 201901112
Feb 20190718
Mar 201902217
Apr 201902215
May 20190147
Jun 20190174
Jul 20190164
Aug 20190168
Sep 2019083
Oct 20190114
Nov 201901110
Dec 20190114
Jan 2020063
Feb 20200135
Mar 2020063
Apr 2020062
May 2020032
Jun 2020063
Jul 20200112
Aug 2020054
Sep 2020070
Oct 20200103
Nov 2020075
Dec 2020084
Jan 2021084
Feb 2021056

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 360 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 360, Issue 2
1 Feb 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Tenofovir Disoproxil Fumarate Is Not an Inhibitor of Human Organic Cation Transporter 1
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleLetters to the Editor

TDF is not an Inhibitor of OCT1

Hong Shen, Wenying Li, W. Griffith Humphreys and Yurong Lai
Journal of Pharmacology and Experimental Therapeutics February 1, 2017, 360 (2) 341-342; DOI: https://doi.org/10.1124/jpet.116.238337

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleLetters to the Editor

TDF is not an Inhibitor of OCT1

Hong Shen, Wenying Li, W. Griffith Humphreys and Yurong Lai
Journal of Pharmacology and Experimental Therapeutics February 1, 2017, 360 (2) 341-342; DOI: https://doi.org/10.1124/jpet.116.238337
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Letters to the Editor
  • Letters to the Editor
Show more LETTERS TO THE EDITOR

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics